[HTML][HTML] Development of novel patient-derived xenografts from breast cancer brain metastases
MJ Contreras-Zárate, DR Ormond, AE Gillen… - Frontiers in …, 2017 - frontiersin.org
Brain metastases are an increasing burden among breast cancer patients, particularly for
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
MJ Contreras-Zárate, DR Ormond… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
Brain metastases are an increasing burden among breast cancer patients, particularly for
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
[PDF][PDF] Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
MJ Contreras-Zárate, DR Ormond, AE Gillen… - Frontiers in …, 2017 - academia.edu
Frontiers in Oncology| www. frontiersin. org November 2017| Volume 7| Article 252 cancer
brain metastasis. These novel BM-PDXs represent heterogeneous and clinically relevant …
brain metastasis. These novel BM-PDXs represent heterogeneous and clinically relevant …
[HTML][HTML] Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
MJ Contreras-Zárate, DR Ormond, AE Gillen… - Frontiers in …, 2017 - ncbi.nlm.nih.gov
Brain metastases are an increasing burden among breast cancer patients, particularly for
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
[引用][C] Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
MJ Contreras-Zárate, DR Ormond, AE Gillen… - Frontiers in …, 2017 - cir.nii.ac.jp
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
MJ Contreras-Zárate, DR Ormond, AE Gillen… - Frontiers in …, 2017 - europepmc.org
Brain metastases are an increasing burden among breast cancer patients, particularly for
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
MJ Contreras-Zárate, DR Ormond, AE Gillen… - Frontiers in …, 2017 - europepmc.org
Brain metastases are an increasing burden among breast cancer patients, particularly for
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …
those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the …